Sana Syed1, Ellen S Michalski, Vin Tangpricha, Supavit Chesdachai, Archana Kumar, Jarod Prince, Thomas R Ziegler, Parminder S Suchdev, Subra Kugathasan. 1. *Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia; †Division of Gastroenterology, Hepatology and Nutrition, Children's Healthcare of Atlanta, Atlanta, Georgia; ‡Nutrition and Health Sciences Program, Laney Graduate School, Emory University, Atlanta, Georgia; §Department of Medicine, Emory University School of Medicine; and ‖Atlanta VA Medical Center, Atlanta, Georgia.
Abstract
BACKGROUND: Anemia, iron deficiency, and hypovitaminosis D are well-known comorbidities in inflammatory bowel disease (IBD). Epidemiologic studies have linked vitamin D deficiency with increased risk of anemia, and in vitro studies suggest that vitamin D may improve iron recycling through downregulatory effects on hepcidin and proinflammatory cytokines. METHODS: We aimed to investigate the association of vitamin D status with inflammation, iron biomarkers, and anemia in pediatric IBD. Cross-sectional data were obtained from N = 69 patients with IBD aged 5 to <19 years. Iron biomarkers (ferritin, soluble transferrin receptor), and 25-hydroxyvitamin D (25(OH)D), inflammatory biomarkers (C-reactive protein and α-1-acid glycoprotein), hepcidin, and hemoglobin were collected. Iron biomarkers were regression corrected for inflammation. Multivariable logistic/linear models were used to examine the associations of 25(OH)D with inflammation, iron status, hepcidin, and anemia. RESULTS: Approximately 50% of subjects were inflamed (C-reactive protein >5 mg/L or α-1-acid glycoprotein >1 g/L). Iron deficiency prevalence (inflammation-corrected ferritin <15 μg/L or soluble transferrin receptor >8.3 mg/L) was 67%; anemia was 36%, and vitamin D insufficiency (25(OH)D <30 ng/mL) was 77%. In linear regression models, vitamin D insufficiency was associated with increased hepcidin levels (β [SE] = 0.6 [0.2], P = 0.01) and reduced hemoglobin (β [SE] = -0.9 [0.5], P = 0.046), controlling for age, sex, race, insurance status, body mass index for age, inflammation, disease diagnosis (ulcerative colitis versus Crohn's disease), and disease duration, compared with 25(OH)D ≥30 ng/mL. CONCLUSIONS: Our results suggest that concentrations of 25(OH)D ≥30 ng/mL are associated with lower hepcidin and higher hemoglobin levels. Further research is needed to clarify the association of vitamin D with inflammation, iron status, and anemia in pediatric IBD.
BACKGROUND:Anemia, iron deficiency, and hypovitaminosis D are well-known comorbidities in inflammatory bowel disease (IBD). Epidemiologic studies have linked vitamin D deficiency with increased risk of anemia, and in vitro studies suggest that vitamin D may improve iron recycling through downregulatory effects on hepcidin and proinflammatory cytokines. METHODS: We aimed to investigate the association of vitamin D status with inflammation, iron biomarkers, and anemia in pediatric IBD. Cross-sectional data were obtained from N = 69 patients with IBD aged 5 to <19 years. Iron biomarkers (ferritin, soluble transferrin receptor), and 25-hydroxyvitamin D (25(OH)D), inflammatory biomarkers (C-reactive protein and α-1-acid glycoprotein), hepcidin, and hemoglobin were collected. Iron biomarkers were regression corrected for inflammation. Multivariable logistic/linear models were used to examine the associations of 25(OH)D with inflammation, iron status, hepcidin, and anemia. RESULTS: Approximately 50% of subjects were inflamed (C-reactive protein >5 mg/L or α-1-acid glycoprotein >1 g/L). Iron deficiency prevalence (inflammation-corrected ferritin <15 μg/L or soluble transferrin receptor >8.3 mg/L) was 67%; anemia was 36%, and vitamin Dinsufficiency (25(OH)D <30 ng/mL) was 77%. In linear regression models, vitamin Dinsufficiency was associated with increased hepcidin levels (β [SE] = 0.6 [0.2], P = 0.01) and reduced hemoglobin (β [SE] = -0.9 [0.5], P = 0.046), controlling for age, sex, race, insurance status, body mass index for age, inflammation, disease diagnosis (ulcerative colitis versus Crohn's disease), and disease duration, compared with 25(OH)D ≥30 ng/mL. CONCLUSIONS: Our results suggest that concentrations of 25(OH)D ≥30 ng/mL are associated with lower hepcidin and higher hemoglobin levels. Further research is needed to clarify the association of vitamin D with inflammation, iron status, and anemia in pediatric IBD.
Authors: Justine Bacchetta; Joshua J Zaritsky; Jessica L Sea; Rene F Chun; Thomas S Lisse; Kathryn Zavala; Anjali Nayak; Katherine Wesseling-Perry; Mark Westerman; Bruce W Hollis; Isidro B Salusky; Martin Hewison Journal: J Am Soc Nephrol Date: 2013-11-07 Impact factor: 10.121
Authors: Meredith A Atkinson; Michal L Melamed; Juhi Kumar; Cindy N Roy; Edgar R Miller; Susan L Furth; Jeffrey J Fadrowski Journal: J Pediatr Date: 2013-10-08 Impact factor: 4.406
Authors: Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver Journal: J Clin Endocrinol Metab Date: 2011-06-06 Impact factor: 5.958
Authors: Sana Syed; Subra Kugathasan; Archana Kumar; Jarod Prince; Bess T Schoen; Courtney McCracken; Thomas R Ziegler; Parminder S Suchdev Journal: J Pediatr Gastroenterol Nutr Date: 2017-05 Impact factor: 2.839
Authors: Susan J van Rensburg; Ronald van Toorn; Rajiv T Erasmus; Coenraad Hattingh; Clint Johannes; Kelebogile E Moremi; Merlisa C Kemp; Penelope Engel-Hills; Maritha J Kotze Journal: Metab Brain Dis Date: 2021-04-28 Impact factor: 3.584
Authors: Reagan M Mogire; John Muthii Muriuki; Alireza Morovat; Alexander J Mentzer; Emily L Webb; Wandia Kimita; Francis M Ndungu; Alex W Macharia; Clare L Cutland; Sodiomon B Sirima; Amidou Diarra; Alfred B Tiono; Swaib A Lule; Shabir A Madhi; Andrew M Prentice; Philip Bejon; John M Pettifor; Alison M Elliott; Adebowale Adeyemo; Thomas N Williams; Sarah H Atkinson Journal: Nutrients Date: 2022-03-25 Impact factor: 5.717
Authors: Susan J van Rensburg; Armand V Peeters; Ronald van Toorn; Johan Schoeman; Kelebogile E Moremi; Carel J van Heerden; Maritha J Kotze Journal: Mol Genet Metab Rep Date: 2019-03-23
Authors: Camille G Apple; Elizabeth S Miller; Kolenkode B Kannan; Julie A Stortz; Michael Cox; Tyler J Loftus; Hari K Parvataneni; Matthew Patrick; Jennifer E Hagen; Scott Brakenridge; Philip A Efron; Alicia M Mohr Journal: J Trauma Acute Care Surg Date: 2020-12 Impact factor: 3.697